Detalhe da pesquisa
1.
Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health.
Curr Osteoporos Rep
; 21(4): 386-400, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289382
2.
Immobilization of Denosumab on Titanium Affects Osteoclastogenesis of Human Peripheral Blood Monocytes.
Int J Mol Sci
; 20(5)2019 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813507
3.
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice.
Calcif Tissue Int
; 99(1): 99-109, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26945756
4.
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine.
Eur Heart J
; 40(33): 2825-2830, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169643
5.
Transient muscle paralysis degrades bone via rapid osteoclastogenesis.
FASEB J
; 26(3): 1110-8, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22125315
6.
Twelve Months of Denosumab and/or Alendronate Is Associated With Improved Bone Fatigue Life, Microarchitecture, and Density in Ovariectomized Cynomolgus Monkeys.
J Bone Miner Res
; 38(3): 403-413, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533719
7.
Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman Primates.
J Bone Joint Surg Am
; 105(15): 1145-1155, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37159527
8.
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.
Endocr Rev
; 29(2): 155-92, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18057140
9.
Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability.
Calcif Tissue Int
; 90(4): 330-42, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382900
10.
Denosumab treatment is associated with decreased cortical porosity and increased bone density and strength at the proximal humerus of ovariectomized cynomolgus monkeys.
Bone
; 164: 116517, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961611
11.
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
J Biol Chem
; 285(36): 28164-73, 2010 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20558734
12.
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice.
Am J Pathol
; 175(2): 473-8, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19590040
13.
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects.
Sci Rep
; 10(1): 16217, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004873
14.
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.
Circulation
; 117(3): 411-20, 2008 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18172035
15.
Effects of spaceflight on murine skeletal muscle gene expression.
J Appl Physiol (1985)
; 106(2): 582-95, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074574
16.
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis.
Clin Exp Metastasis
; 25(2): 119-29, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18064531
17.
The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis.
Biomarkers
; 13(7): 692-712, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19096963
18.
Serum calcium concentration is maintained when bone resorption is suppressed by osteoprotegerin in young growing male rats.
Bone
; 116: 162-170, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30077758
19.
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.
J Mol Med (Berl)
; 96(6): 559-573, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736604
20.
Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone.
J Bone Miner Res
; 22(10): 1534-47, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17576164